Home NDC 71767-111-01 FUROSCIX
Product NDC 71767-111
Requested package NDC 71767-111-01
11-digit product format 717670111
Labeler code 71767
Product ID 71767-111_57ef4d44-0cc5-db23-e063-6294a90a50cc
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name furosemide
Dosage form INJECTION
Route SUBCUTANEOUS
Labeler scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation
Application NDA209988
Marketing category NDA
Marketing start 2026-07-27
Substance FUROSEMIDE
Active strength 80 mg/mL
Pharmacologic classes Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209988-001 FUROSCIX FUROSEMIDE 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 N209988-002 FUROSCIX READYFLOW (AUTOINJECTOR) FUROSEMIDE 80MG/ML (80MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-07-23
Orange Book patents# Current patent rows page 1 of 1 · 14 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209988-001 10272064 2034-04-03 Drug product 2022-11-02 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 N209988-001 12370168 2034-04-03 U-3462 Drug product 2025-08-22 N209988-001 9884039 2034-04-03 U-3462 2022-11-02 N209988-002 11497755 2040-01-30 Drug product 2026-08-21 N209988-002 11559535 2040-01-30 Drug product 2026-08-21 N209988-002 11571434 2040-01-30 Drug product 2026-08-21 N209988-002 11998555 2040-01-30 U-4589 Drug product 2026-08-21 N209988-002 12048709 2040-01-30 U-4588 Drug product 2026-08-21 N209988-002 12491193 2040-01-30 U-4588 Drug product 2026-08-21 N209988-002 12491194 2040-01-30 U-4588 Drug product 2026-08-21 N209988-002 12491195 2040-01-30 U-4588 Drug product 2026-08-21 N209988-002 12491196 2040-01-30 U-4588 Drug product 2026-08-21 N209988-002 12491197 2040-01-30 U-4588 Drug product 2026-08-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 FUROSCIX READYFLOW (AUTOINJECTOR) 80MG/ML (80MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-07-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209988-002 FUROSCIX READYFLOW (AUTOINJECTOR) 80MG/ML (80MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-07-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 3a93d1ddd44b…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N209988-001 FUROSCIX 80MG/10ML (8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-10-07 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 3 · 96 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N209988-001 10272064 2034-04-03 Drug product 2022-11-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-001 12370168 2034-04-03 U-3462 Drug product 2025-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-001 9884039 2034-04-03 U-3462 2022-11-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 11497755 2040-01-30 Drug product 2026-08-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 11559535 2040-01-30 Drug product 2026-08-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 11571434 2040-01-30 Drug product 2026-08-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 11998555 2040-01-30 U-4589 Drug product 2026-08-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 12048709 2040-01-30 U-4588 Drug product 2026-08-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 12491193 2040-01-30 U-4588 Drug product 2026-08-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 12491194 2040-01-30 U-4588 Drug product 2026-08-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 12491195 2040-01-30 U-4588 Drug product 2026-08-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 12491196 2040-01-30 U-4588 Drug product 2026-08-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209988-002 12491197 2040-01-30 U-4588 Drug product 2026-08-21 84e616aacf4f…2026-08-18 06:07:40 2026-07 N209988-001 10272064 2034-04-03 Drug product 2022-11-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209988-001 12370168 2034-04-03 U-3462 Drug product 2025-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209988-001 9884039 2034-04-03 U-3462 2022-11-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209988-001 10272064 2034-04-03 Drug product 2022-11-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209988-001 12370168 2034-04-03 U-3462 Drug product 2025-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209988-001 9884039 2034-04-03 U-3462 2022-11-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209988-001 10272064 2034-04-03 Drug product 2022-11-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209988-001 12370168 2034-04-03 U-3462 Drug product 2025-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209988-001 9884039 2034-04-03 U-3462 2022-11-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209988-001 10272064 2034-04-03 Drug product 2022-11-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209988-001 9884039 2034-04-03 U-3462 2022-11-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209988-001 10272064 2034-04-03 Drug product 2022-11-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209988-001 9884039 2034-04-03 U-3462 2022-11-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209988-001 10272064 2034-04-03 Drug product 2022-11-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209988-001 9884039 2034-04-03 U-3462 2022-11-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209988-001 10272064 2034-04-03 Drug product 2022-11-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209988-001 9884039 2034-04-03 U-3462 2022-11-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209988-001 10272064 2034-04-03 Drug product 2022-11-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209988-001 11433044 2034-04-03 U-3462 2022-11-02 2680178bc6a6…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209988-001 NP 2025-10-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209988-001 NP 2025-10-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209988-001 NP 2025-10-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209988-001 NP 2025-10-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209988-001 NP 2025-10-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209988-001 NP 2025-10-07 2680178bc6a6…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209988-001 NP 2025-10-07 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209988-001 NP 2025-10-07 d06236e962d9…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base FUROSCIX
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FUROSEMIDE 80 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7LXU5N7ZO5 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2621022 Internal RxNorm lookup 2621028 Internal RxNorm lookup 2747765 Internal RxNorm lookup 2747769 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 71767-111-01 71767011101 1 SYRINGE, GLASS in 1 CARTON (71767-111-01) / 1 mL in 1 SYRINGE, GLASS 2026-07-27 No No Current